Header Image

Investor Relations

Investor Relations

Investor Relations

Corporate Profile

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, email us.

Copyright Nasdaq. Minimum 15 minutes delayed.

May 8, 2018

RESEARCH TRIANGLE PARK, N.C. , May 08, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today financial results for the first quarter ended March 31, 2018 . “We are off to a strong start in 2018 as we continue to make progress advancing all our HAE development